BACKGROUND The aim of the present study was to investigate risk factors for developing more severe @entity788 , including moderately severe (MSAP) and @entity656 ( @entity656 ), in @entity1 admitted with @entity656 ( @entity656 ). MATERIAL AND METHODS @entity1 admitted with @entity656 to our hospital from March 2013 to May 2016 were included and prospectively evaluated. Possible risk factors for developing MSAP or @entity656 were age, blood @entity413 level on admission, etiology, sex, Ranson score, amylase level, Acute Physiology and Chronic Health Evaluation II (APACHE-II) scores, @entity1851 ( @entity1851 ) level, serum @entity460 level, visceral fat area (VFA), body mass index (BMI), whether this was the first episode of AP, and method of administration of @entity2390 . The effects of variables for developing MSAP or @entity656 were evaluated using univariate and multivariate logistic regression models. Mortality, hospital duration, and rate of ICU transfer of @entity1 were compared between @entity1 who developed MSAP or @entity656 and @entity1 who did not. RESULTS A total of 602 @entity1 admitted with @entity656 were recruited into this study (256 @entity1 and 346 @entity1 ). Seventy-four @entity1 (12.3%) developed MSAP or @entity656 . According to univariate logistic regression analyses, the results indicated that there were 5 significant differences between @entity1 who developed MSAP or @entity656 and those who did not: VFA (>100 cm  ) (p=0.003), BMI (>= 25 kg/m  ) (p=0.001), Ranson score(p=0.004), APACHE-II (>= 5) (p=0.001), and blood @entity413 level on admission (>11.1 mmol/L) (p=0.040). Further multivariate logistic regression analyses revealed that BMI (>= 25 kg/m  ) (p=0.005), APACHE-II (>= 5) (p=0.001), and blood @entity413 level on admission (>11.1 mmol/L) (p=0.004) were independent risk factors for developing MSAP or @entity656 in @entity1 admitted with @entity656 . Moreover, @entity1 who developed MSAP or @entity656 had a mortality rate of 5.4%. CONCLUSIONS Significant risk factors for developing MSAP or @entity656 in @entity1 admitted with @entity656 included BMI (>= 25 kg/m  ), APACHE-II (>= 5), and blood @entity413 level on admission (>11.1 mmol/L). These factors should be used in the prediction of more severe @entity788 in @entity1 admitted with @entity656 .

Risk Factors for Worsening of Acute @entity788 in @entity1 Admitted with Mild Acute XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients', 'men'] @entity788 :: ('MESH:D010190', 'Disease') :: ['pancreatitis'] @entity656 :: ('MESH:D019283', 'Disease') :: ['SAP', 'MAP', 'severe acute pancreatitis', 'mild acute pancreatitis'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium'] @entity2390 :: ('MESH:D015282', 'Chemical') :: ['octreotide'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity1851 :: ('1401', 'Gene') :: ['C-reactive protein', 'CRP']
@entity788 :: (MESH:D010190,Disease) :: ['Pancreatitis']
